Putative in vivo kinases: 

An enzyme-substrate reaction that occurs within living cells; includes cultured cells, ex vivo samples, and intact organisms. In the case of kinases, the large number of protein kinases in intact cells makes exact identification of the responsible kinase challenging.

CDK1 S391-p
Pim1 S1149-p
Regulatory protein:
CSFR Y598-p , Y675-p , Y823-p
VHL S306-p , T350-p , S523-p , T527-p , S560-p , S577-p , S594-p , S620-p , S915-p , S1100-p , S1176-p
Treatment:
angiotensin_2 S306-p , S308-p , S560-p , S973-p
AZD1152 T520-p
BI2536 S518-p , T527-p , S915-p
dasatinib S915-p
EGF S306-p , S365-p , S388-p , S391-p , S679-p , S1100-p , S1174-p , S1176-p
ephrin_B1 Y598-p , Y632-p , Y675-p , Y742-p , Y823-p
ephrin_B2 Y542-p , Y632-p , Y653-p , Y675-p , Y823-p
erlotinib Y598-p , Y653-p , Y675-p , Y742-p
FGF2 Y598-p , Y632-p , Y675-p , S730-p , Y742-p , Y803-p , Y814-p , Y823-p , Y978-p
high-fat diet S731-p
hypoxia S306-p , T350-p , S523-p , T527-p , S560-p , S577-p , S594-p , S620-p , S915-p , S1100-p , S1176-p
insulin S1149-p
ischemia S346-p , T544-p , S594-p , S679-p
LRRK2-IN-1 S391-p , S594-p , S973-p
metastatic potential S306-p , S577-p , S594-p , S915-p , S1176-p
MLN8054 S915-p
nocodazole S560-p , S594-p , S1162-p , S1164-p
PI-103 S594-p
SB202190 S1174-p
selumetinib S679-p , S1203-p , S1237-p
SII_angiotensin_2 S731-p , S735-p , S736-p
Su11274 T363-p , Y598-p , Y653-p , Y742-p , Y823-p
U0126 T363-p , S388-p , S391-p
vemurafenib S365-p , S679-p , S1174-p , S1203-p
Y27632 S365-p , S518-p , S679-p , S828-p , S1148-p , S1149-p , S1162-p , S1164-p
ZM447439 T520-p